Literature DB >> 18802099

Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice.

Emily K Forbes1, Clare Sander, Edward O Ronan, Helen McShane, Adrian V S Hill, Peter C L Beverley, Elma Z Tchilian.   

Abstract

Boosting bacillus Calmette-Guérin (BCG)-primed mice with a recombinant adenovirus expressing Mycobacterium tuberculosis Ag 85A by different administration routes has very different effects on protection against aerosol challenge with M. tuberculosis. Mice boosted intradermally make very strong splenic CD4 and CD8 Th1 cytokine responses to Ag 85A, but show no change in lung mycobacterial burden over BCG primed animals. In contrast, intranasally boosted mice show greatly reduced mycobacterial burden and make a much weaker splenic response but a very strong lung CD4 and CD8 response to Ag 85A and an increased response to purified protein derivative. This effect is associated with the presence in the lung of multifunctional T cells, with high median fluorescence intensity and integrated median fluorescence intensity for IFN-gamma, IL-2, and TNF. In contrast, mice immunized with BCG alone have few Ag-specific cells in the lung and a low proportion of multifunctional cells, although individual cells have high median fluorescence intensity. Successful immunization regimes appear to induce Ag-specific cells with abundant intracellular cytokine staining.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802099      PMCID: PMC2867031          DOI: 10.4049/jimmunol.181.7.4955

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin.

Authors:  David Masopust; Vaiva Vezys; Edward J Usherwood; Linda S Cauley; Sara Olson; Amanda L Marzo; Richard L Ward; David L Woodland; Leo Lefrançois
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

2.  Preferential migration of effector CD8+ T cells into the interstitium of the normal lung.

Authors:  Elena Galkina; Jayant Thatte; Vrushali Dabak; Mark B Williams; Klaus Ley; Thomas J Braciale
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

3.  A simple device for the exposure of animals to infectious microorganisms by the airborne route.

Authors:  R J Phillpotts; T J Brooks; C S Cox
Journal:  Epidemiol Infect       Date:  1997-02       Impact factor: 2.451

4.  A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure.

Authors:  Valerie Julia; Edith M Hessel; Laurent Malherbe; Nicolas Glaichenhaus; Anne O'Garra; Robert L Coffman
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

5.  Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.

Authors:  Jun Wang; Lisa Thorson; Richard W Stokes; Michael Santosuosso; Kris Huygen; Anna Zganiacz; Mary Hitt; Zhou Xing
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

6.  Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen.

Authors:  Michael Santosuosso; Xizhong Zhang; Sarah McCormick; Jun Wang; Mary Hitt; Zhou Xing
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

7.  Early lesion formation in cattle experimentally infected with Mycobacterium bovis.

Authors:  J P Cassidy; D G Bryson; J M Pollock; R T Evans; F Forster; S D Neill
Journal:  J Comp Pathol       Date:  1998-07       Impact factor: 1.311

8.  Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells.

Authors:  Jun Wang; Michael Santosuosso; Patricia Ngai; Anna Zganiacz; Zhou Xing
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

9.  Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.

Authors:  Nilu P Goonetilleke; Helen McShane; Carolyn M Hannan; Richard J Anderson; Roger H Brookes; Adrian V S Hill
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

10.  The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice.

Authors:  T Mogues; M E Goodrich; L Ryan; R LaCourse; R J North
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

View more
  151 in total

1.  Suppressed type 1, type 2, and type 17 cytokine responses in active tuberculosis in children.

Authors:  N Pavan Kumar; R Anuradha; R Suresh; R Ganesh; Janani Shankar; V Kumaraswami; Thomas B Nutman; Subash Babu
Journal:  Clin Vaccine Immunol       Date:  2011-09-28

2.  A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.

Authors:  Thomas J Scriba; Michele Tameris; Erica Smit; Linda van der Merwe; E Jane Hughes; Blessing Kadira; Katya Mauff; Sizulu Moyo; Nathaniel Brittain; Alison Lawrie; Humphrey Mulenga; Marwou de Kock; Lebohang Makhethe; Esme Janse van Rensburg; Sebastian Gelderbloem; Ashley Veldsman; Mark Hatherill; Hendrik Geldenhuys; Adrian V S Hill; Anthony Hawkridge; Gregory D Hussey; Willem A Hanekom; Helen McShane; Hassan Mahomed
Journal:  Am J Respir Crit Care Med       Date:  2012-01-26       Impact factor: 21.405

3.  Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease.

Authors:  Lerisa Govender; Brian Abel; E Jane Hughes; Thomas J Scriba; Benjamin M N Kagina; Marwou de Kock; Gerhard Walzl; Gillian Black; Ida Rosenkrands; Gregory D Hussey; Hassan Mahomed; Peter Andersen; Willem A Hanekom
Journal:  Vaccine       Date:  2010-10-23       Impact factor: 3.641

Review 4.  Viruses as vaccine vectors for infectious diseases and cancer.

Authors:  Simon J Draper; Jonathan L Heeney
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

5.  Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by gamma interferon.

Authors:  Xiaoti Guo; Lisa Barroso; Steven M Becker; David M Lyerly; Thomas S Vedvick; Steven G Reed; William A Petri; Eric R Houpt
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

6.  Differentiation of antigen-specific T cells with limited functional capacity during Mycobacterium tuberculosis infection.

Authors:  Yun Hee Jeong; Bo-Young Jeon; Sun-Hwa Gu; Sang-Nae Cho; Sung Jae Shin; Jun Chang; Sang-Jun Ha
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

7.  Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.

Authors:  Patricia A Darrah; Diane L Bolton; Andrew A Lackner; Deepak Kaushal; Pyone Pyone Aye; Smriti Mehra; James L Blanchard; Peter J Didier; Chad J Roy; Srinivas S Rao; David A Hokey; Charles A Scanga; Donata R Sizemore; Jerald C Sadoff; Mario Roederer; Robert A Seder
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

8.  Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells.

Authors:  Thomas J Scriba; Michele Tameris; Nazma Mansoor; Erica Smit; Linda van der Merwe; Fatima Isaacs; Alana Keyser; Sizulu Moyo; Nathaniel Brittain; Alison Lawrie; Sebastian Gelderbloem; Ashley Veldsman; Mark Hatherill; Anthony Hawkridge; Adrian V S Hill; Gregory D Hussey; Hassan Mahomed; Helen McShane; Willem A Hanekom
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

9.  Mycobacterium tuberculosis-Induced Bronchoalveolar Lavage Gene Expression Signature in Latent Tuberculosis Infection Is Dominated by Pleiotropic Effects of CD4+ T Cell-Dependent IFN-γ Production despite the Presence of Polyfunctional T Cells within the Airways.

Authors:  Jessica Jarvela; Michelle Moyer; Patrick Leahy; Tracey Bonfield; David Fletcher; Wambura N Mkono; Htin Aung; David H Canaday; Jean-Eudes Dazard; Richard F Silver
Journal:  J Immunol       Date:  2019-09-20       Impact factor: 5.422

10.  Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.

Authors:  Shruthi Ravimohan; Neo Tamuhla; Kebatshabile Nfanyana; Andrew P Steenhoff; Rona Letlhogile; Ian Frank; Rob Roy MacGregor; Robert Gross; Drew Weissman; Gregory P Bisson
Journal:  Clin Infect Dis       Date:  2015-11-26       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.